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Werecently demonstrated that expression of a-defensins, themajor antimicrobial peptides produced byPaneth
cells, was severely suppressed in mice with graft-versus-host disease (GVHD). In this study, we found that
antibacterial lectin, regenerating islet-derived IIIg (RegIIIg) was upregulated in villous enterocytes, thus
demonstrating the reciprocal control of enteric antimicrobial proteins in GVHD. Upregulation of RegIIIg was
mediated by a mechanism independent upon radiation-induced intestinal tract damage. MyD88-mediated
signaling in intestinal epithelium was required for RegIIIg upregulation in GVHD and antibiotic therapy
downregulated RegIIIg expression. These results suggest that MyD88-mediated sensing of the intestinal
microbes disregulated in GVHD induces RegIIIg upregulation in GVHD and argue a role for RegIIIg in the
pathogenesis of GVHD.
 2013 American Society for Blood and Marrow Transplantation.INTRODUCTION peptides. Among them, a-defensins are the most potent
Allogeneic hematopoietic stem cell transplantation,
a curative therapy for a number of hematologic diseases, is
complicated by graft-versus-host disease (GVHD). Particu-
larly, intestinal GVHD is critical for determining the outcome
of allogeneic bone marrow transplantation (BMT) [1].
Recently, regenerating islet-derived 3a (RegIIIa) was identi-
ﬁed as a speciﬁc biomarker for intestinal GVHD in humans
using a large-scale and quantitative proteomic discovery
approach [2,3]. Reg genes constitute a multigene family,
which is categorized into 4 subclasses. RegIIIg, a homologue
of human RegIIIa in mice, is preferentially expressed in the
small intestine. RegIIIg have canonical C-type lectin domains
that bind to the peptidoglycan, which is an essential
component of the bacterial cell wall and, thus, has direct
antimicrobial activity, speciﬁcally against Gram-positive
bacteria and protects the epithelial barrier function of the
intestinal mucosa [4].
The intestinal microbial communities are actively regu-
lated by Paneth cells through their secretion of antimicrobialantimicrobial peptides that account for 70% of the bactericidal
peptide activity released from Paneth cells [5,6]. We recently
found that Paneth cells were targeted by GVHD, resulting in
marked reduction in the expression of a-defensins [7]. Thus, it
is puzzling why blood levels of RegIIIa levels are elevated,
whereas a-defensins are downregulated, in GVHD. In this
study,weevaluatedenteric expressionofRegIIIg at the cellular
level in mouse models of BMT and found that the major
producers of RegIIIgwere villous enterocytes, not Paneth cells,
in GVHD. Upregulation of RegIIIg in GVHD was dependent
upon MyD88-mediated sensing of the intestinal microﬂora.
MATERIAL AND METHODS
Mice
Female C57BL/6 (B6: H-2b), B6D2F1 (H-2b/d), B6-Ly5.1 (H-2b, CD45.1þ),
BALB.B (H-2b), and C3H.Sw (H-2b) mice were purchased from Charles River
Japan, KBT Oriental, or Japan SLC. B6-background Myeloid differentiation
factor 88 (MyD88)-deﬁcient (MyD88/) mice [8] were kindly provided by
Dr. Kiyoshi Takeda at Osaka University. All animal experiments were per-
formed under the auspices of the Institutional Animal Care and Research
Advisory Committee.
BMT
Mice underwent transplantation as previously described [9]. In brief,
after lethal X-ray total body irradiation delivered in 2 doses at 4 hour
intervals, mice were intravenously injected with 5  106 T celledepleted
bonemarrow (TCD-BM) cells with or without 2106 splenic Tcells on day 0.
Isolation of T cells and T cell depletion were performed using the T cell
isolation kit and anti-CD90-MicroBeads, respectively, and the AutoMACS
(Miltenyi Biotec, Tokyo, Japan) according to the manufacturer’s instructions.
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with 12  107 splenocytes [7,10]. An antibiotic regimen consisted of poly-
myxin B (105 U/kg), metronidazole (30 mg/kg), and vancomycin (30 mg/kg)
(PMV). Mice were maintained in speciﬁc pathogen-free condition and
received normal chow and autoclaved hyperchlorinated water (pH 4) for the
ﬁrst 3 weeks after BMT and ﬁltered water thereafter. The degree of clinical
GVHD was assessed weekly by a scoring system, which sums changes in 5
clinical parameters: weight loss, posture, activity, fur texture, and skin
integrity (maximum index ¼ 10), as described previously [9].
Histological and Immunohistochemical Analysis
For pathological analysis, samples of the small intestine were ﬁxed
in 10% neutral-buffered formalin, embedded in parafﬁn, sectioned, slide
mounted, and stained with H & E. Immunohistochemistry was performed as
described [11] using rabbit antidefensina1 and anti- RegIIIg (Funakoshi,
Tokyo, Japan). Histoﬁne Simple Stain MAX PO (Rat) kits and subsequently
DAB solution (Nichirei Biosciences, Tokyo, Japan) was used to generate
brown-colored signals. Slides were then counterstained with hematoxylin.
Pictures from tissue sections were taken at room temperature using a digital
camera (DP72, Olympus, Tokyo, Japan) mounted on a microscope (BX51,
Olympus, Tokyo, Japan).
Preparation and Analysis of Isolated Mouse Crypts
Individual crypts were isolated from the small intestine as previously
described [6]. Following ﬁxation and permeabilization, isolated crypts were
incubated for 1 hour with FITC-conjugated anti-Lysozyme (10 mg/mL) (Dako,
Tokyo, Japan), followed by incubation for 1 hour with Allexa Fluor 594-
conjugated-phalloidin (1 U/mL) (Life Technologies Corporation, Carlsbad,
CA). Tetramethyl DAPI (5 mg/mL) (Life Technologies Corporation)was used to
stain the nucleus. Samples were mounted in Aqua Poly/Mount (Poly-
sciences, Warrington, PA) and examined with a confocal laser-scanning
microscope (LSM510, Carl Zeiss, Jena, Germany).
ELISA
Serum levels of RegIIIg and IL-22 were measured by using the ELISA
Kit for RegIIIg (USCN, Wuhan, China) and the ELISA Kit for mouse IL-22
(BioLegend, San Diego, CA), respectively.
Quantitative Real-time PCR Analysis
Total RNAwaspuriﬁedusing the RNeasyKit (QIAGEN, Tokyo, Japan). cDNA
was synthesized using a QuantiTect Reverse Transcription Kit (QIAGEN). PCR
reactions and analyses were performed with ABI PRISM 7900HT SDS 2.1 (Life
Technologies Corporation) using TaqMan Universal PCR master mix (Applied
Biosystems), and TaqMan Gene Expression Assays (Defa1: Mm02524428_g1,
RegIIIg Mm01181783_g1, and Gapdh: Mm99999915_g1, Life Technologies
Corporation). The relative amount of each mRNA was determined using the
standard curve method andwas normalized to the level of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) in each sample.
Statistical Analysis
Mann-Whitney U tests were used to compare data. All tests were per-
formed with the SigmaPlot Version 10.0 software. P < .05 was considered
statistically signiﬁcant.
RESULTS
Reciprocal Control of a-defensins and RegIIIg Expression
in GVHD
Lethally irradiated B6D2F1 (H-2b/d) mice received 5  106
TCD-BM alone (control group) or TCD-BM plus 2 106 T cells
(GVHD group) from major histocompatibility complex
(MHC)-mismatched B6 (H-2b) donors on day 0. The alloge-
neic animals developed severe GVHD, as previously
demonstrated (data not shown) [7,10]. Pathological analysis
of the small intestine 7 days after BMT showed mostly
normal architecture in controls, whereas blunting of villi was
observed in the GVHD group (Figure 1A). Confocal cross-
sectioning of individual crypts isolated from the small
intestine demonstrated Paneth cell loss in mice with GVHD,
as previously shown (Figure 1B) [7].
a-Defensins are the major antimicrobial peptides produced
by Paneth cells [6]. Immunohistochemical analysis showed
that defensin a1 expression was limited in Paneth cells in the
crypts of naïve mice (Figure 1C). Expression of defensin a1 waspreserved in controls butwas severely suppressed inmicewith
GVHD 7 days after BMT (Figure 1C). In contrast, RegIIIg
expression was markedly increased in villous enterocytes in
the GVHD group (Figure 1D). It should be noted that major
producers of RegIIIgwere not Paneth cells, and there was little
expression of defensin a1 in enterocytes in GVHD.
To conﬁrm the differential expression of a-defensins and
RegIIIg, their expression levels in the terminal ileum were
evaluated by quantitative real-time PCR analysis. In the
GVHD group, expression of defensin-a1 (Defa1) was markedly
reduced (Figure 1E), whereas RegIIIg expression was signif-
icantly increased (Figure 1F).
RegIIIg Upregulation in GVHD by a Mechanism
Independent Upon Radiation-induced Intestinal Tract
Damage
We evaluated if increased expression of RegIIIg in the
small intestine correlated with increased serum levels of
RegIIIg. Serum levels of RegIIIg were not increased in the
control group after BMT, whereas those were signiﬁcantly
and constantly elevated in the GVHD group (Figure 2A). We
next addressed whether RegIIIg upregulation could be
related to radiation-induced intestinal tract damage, using
an unirradiated B6/ B6D2F1model as previously described
[7,10]. Again, serum levels of RegIIIg were signiﬁcantly and
constantly elevated in the GVHD group to the similar levels
observed in the irradiated model (Figure 2B).
RegIIIg Upregulation in MHC-matched Models of GVHD
We then evaluated if upregulation of RegIIIg could be
observed in clinically relevant, MHC-matched, but minor
histocompatibility antigenemismatched models of BMT.
Again, serum levels of RegIIIg were signiﬁcantly elevated in
the B6/ BALB.B model (Figure 2C) and the C3H.Sw/ B6
model of BMT (Figure 2D).
RegIIIg is Induced by the Stimulation of Intestinal
Microbes Through MyD88-mediated Signaling in
Intestinal Epithelium in GVHD
We investigated mechanisms of upregulation of enteric
expression of RegIIIg in GVHD. Because recognition of
commensal microﬂora by toll-like receptors is required for
intestinal homeostasis and RegIIIg expression is controlled
by microorganism-associated molecular patterns that acti-
vateMyD88 pathway [12-15], we hypothesized that bacterial
stimuli through MyD88 pathway could mediate the upre-
gulation of RegIIIg in GVHD. To test this hypothesis, wild-
type (WT) or MyD88/ B6 mice were used as recipients in
the C3H.Sw/ B6 model of BMT. Clinical GVHD scores were
not signiﬁcantly different between WT and MyD88/ mice
on days 28 and 35 after BMT (Supplemental Figure 1A).
Nonetheless, serum levels of RegIIIgwere signiﬁcantly lower
in MyD88/ mice than in WT mice on day 28 and day 35
after BMT (Figure 2E).
We and others have shown that GVHD induces dramatic
alteration in the intestinal microbiota [7,16,17]. We, there-
fore, hypothesized that upregulated expression of RegIIIg
might be a natural mechanism of adaptation aimed to restore
normal intestinal ecology. To evaluate whether modifying
the enteric ﬂora using oral antibiotics could inhibit upregu-
lation of RegIIIg, we treated mice with broad-spectrum
antibiotic combination as described, with a slight modiﬁca-
tion [14]. PMV was administered by daily oral gavage from
day 14 in the C3H.Sw/ B6 model of BMT. It reduced clinical
GVHD scores, as previously described (Supplemental
Figure 1. Reciprocal control of expression of Paneth cell-derived a-defensins and epithelial cell-derived RegIIIg in GVHD. Lethally irradiated B6D2F1 mice underwent
transplantation with T celledeprived bone marrow (TCD-BM) cells without (control group) or with T cells (GVHD group) from MHC-mismatched B6 donors. Small
intestines were isolated from mice 7 days after BMT. (A) Histology of the small intestine stained with H & E. (B) Confocal cross-sectioning of the isolated small
intestinal crypt. Lysozyme (green) is expressed by Paneth cells. Tetramethyl DAPI (blue) stains the nucleus and phalloidin (red) stains F-actin. Magniﬁcation: 1000.
Bars, 10 mm. Immunohistochemical staining for defensin a1 (brown) (C) and RegIIIg (brown) (D). Magniﬁcation: 100. Bars, 100 mm. RNAwas extracted from the small
intestines on day 7 and quantitative real-time PCR analysis for Defa1 (E) and RegIIIg (F) compared to GAPDH was performed (n ¼ 6 per group). Data are representative
of 2 similar experiments and are shown as means  SE. *P < .05.
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gulation of RegIIIg on day 28 after BMT (Figure 2F).
Induction of RegIIIg also requires IL-22-mediated signals
from innate lymphoid cells [18,19]. However, serum levels of
IL-22 were signiﬁcantly lower in the GVHD group than in
controls on day 28 and day 35 after BMT in the C3H.Sw/ B6
model (Supplemental Figure 1C). Gut decontamination with
the PMV regimen or the use of MyD88/ B6 mice did not
change serum levels of IL-22 (data not shown).
DISCUSSION
Epithelial antimicrobial proteins have an essential role
in allowing epithelial surfaces to cope with microbialchallenges. They include defensins, cathelicidins, and C-type
lectins, such as the Reg family [20]. In this study, we found
that enteric expression of a-defensins and RegIIIg was
reciprocally controlled in GVHD. This was due to the differ-
ence in the major producers of these molecules in GVHD. It
has been shown that a-defensins are exclusively produced by
Paneth cells, whereas RegIIIg is produced by both villous
enterocytes and Paneth cells in steady state [13,21]. In GVHD,
enterocyte production of RegIIIg was markedly increased,
whereas Paneth cell production of a-defensins was severely
suppressed.
Intestinal GVHD is characterized by severe villous atrophy
and crypt degeneration. Crypt cell apoptosis is 1 of the initial
Figure 2. Increased serum levels of RegIIIg in GVHD is inhibited by intestinal decontamination or in the absence of MyD88 signaling pathway in hosts. Serum levels of
RegIIIgwere measured after BMT (n¼ 6 per group). Data are representative of 2 similar experiments and are shown as means SE. *P < .05. (A) Irradiated B6/ B6D2F1
model. (B) Unirradiated B6/ B6D2F1 model. (C) Irradiated B6/ BALB.B model. (D) Irradiated C3H.Sw/ B6 model. (E) Irradiated C3H.Sw/ B6 model. B6 mice were
either WT or MyD88/ B6 mice. (F) Irradiated C3H.Sw/ B6 model. A cohort of mice were treated with PMV regimen by daily oral gavage from day 14 of BMT.
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[22,23]. Experimental and clinical evidence favor the idea
that crypt cells are the principal focus of the attack by donor
T cells and inﬂammatory cytokines in GVHD [24]. Intestinal
stem cells and their niche, Paneth cells reside in the crypts
and we have shown that both intestinal stem cells and
Paneth cells are targeted by GVHD [7,10]. In contrast, there is
little evidence of direct damage tomature villous enterocytes
in mild GVHD and damage to mature enterocyte appears
only at severe stage, suggesting that these events are
secondary to the alterations in crypt cell turnover [22-25].
Serum levels of RegIIIg were increased in an unirradiated
model of BMT, demonstrating a mechanism independent
upon radiation-induced intestinal tract damage. These
results are consistent with our recent observation that GVHD
induces Paneth cell injury and subsequent dysbiosis by
a mechanism independent upon conditioning [7]. A recent
clinical study demonstrated that low Paneth cell numbers at
onset of intestinal GVHD are associated with high risk for
nonrelapse mortality [26].
We have shown that MyD88-mediated signaling in host
nonhematopoietic cells is required for upregulation of
RegIIIg in villous enterocytes in GVHD. Because severity of
GVHD was not altered in MyD88/mice as has been shown
[27], downregulation of RegIIIg was not secondary toamelioration of GVHD. These results suggest a potential lack
of reliability of RegIIIg as a marker for GVHD and argue
against a role for it in the pathophysiology of GVHD.
Administration of the broad-spectrum antibiotic combina-
tion PMV markedly decreased serum levels of RegIIIg in
GVHD. These results are consistent with previous studies
demonstrating that RegIIIg expression is controlled by
microorganism-associated molecular patterns that activate
MyD88 pathway in nonhematopoietic cells in steady state
and in bacterial infection [12-15,17]. Sensitivity of RegIIIg as
a biomarker of intestinal GVHD may be reduced when
intensive and broad antibiotics are administered.
We and others have shown that development of intestinal
GVHD induced marked dysbiosis in the intestinal ﬂora in
mice and human [7,16,17,28]. Although dominantly expanded
bacteria in GVHD differs at institutions [7,16,17], we found the
prominent outgrowth of Gram-negative bacteria, Escherichia
coli in the intestinal ﬂora in GVHD [7], thus supporting the
previous ﬁndings that Gram-negative bacteria, but not
Gram-positive bacteria, induces RegIIIg expression [14,29].
Thus, it is tempting to assume that enhanced production
of RegIIIg is a natural adaptationmechanism for the dysbiosis
in GVHD. Paneth cell metaplasia is also observed in the
colon of GVHD patients, probably as an adaptation mecha-
nism for Paneth cell loss and the dysbiosis [30].
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production is markedly inhibited in GVHD that have selective
bactericidal activity mostly against Gram-negative bacteria
[7,31,32]. On the other hand, the antibacterial activity of
RegIIIg is likely restricted to Gram-positive bacteria because
of their accessibility to peptidoglycan on the cell surface of
Gram-positive bacteria [4]. Thus, bacteria belonging to
different classes may battle against each other by stimulating
innate antimicrobial mechanisms that selectively inactivate
speciﬁc bacteria in themammalian gut, and dramatic decrease
in a ratio of a-defensins to RegIIIg production may be in tune
with overwhelming outgrowth of Gram-negative bacteria.
RegIIIg mRNA expression also requires IL-22-mediated
signals from innate lymphoid cells [18,19]. However, IL-22
was reduced in GVHD in our study. Hanash et al. recently
demonstrated that IL-22eproducing innate lymphoid cells
were eliminated in GVHD; however, RegIIIg was still
expressed in GVHD in IL-22/ mice, suggesting that RegIIIg
expression was upregulated by IL-22 independent pathways
in the presence of minimum amounts of IL-22 in GVHD [33].
Recently, RegIIIa is identiﬁed as a speciﬁc biomarker for
intestinal GVHD in human using a large-scale and quantita-
tive proteomic discovery approach [2,3]. Our results support
these studies and give mechanistic insights. These new
insights will help to understand pathophysiology of GVHD in
the context of host-microbe interaction and to establish new
therapeutic strategies that can improve clinical outcome of
allogeneic stem cell transplantation.
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